C WorldWide Group’s TherapeuticsMD TXMD Stock Holding History

C WorldWide Group’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-123,797	Closed	-$2.35M	–	92
2022 Q1	$2.35M	Hold	123,797	–	–	0.03%	72
2021 Q4	$2.2M	Hold	123,797	–	–	0.02%	78
2021 Q3	$4.59M	Hold	123,797	–	–	0.05%	68
2021 Q2	$7.37M	Hold	123,797	–	–	0.08%	52
2021 Q1	$8.29M	Hold	123,797	–	–	0.08%	57
2020 Q4	$7.49M	Hold	123,797	–	–	0.08%	59
2020 Q3	$9.78M	Hold	123,797	–	–	0.11%	50
2020 Q2	$7.74M	Hold	123,797	–	–	0.09%	56
2020 Q1	$6.56M	Buy	123,797 +60,000	+94%	+$5.95M	0.09%	51
2019 Q4	$7.72M	Hold	63,797	–	–	0.09%	56
2019 Q3	$11.6M	Hold	63,797	–	–	0.15%	42
2019 Q2	$8.29M	Buy	63,797 +44,000	+222%	+$7.89M	0.1%	54
2019 Q1	$4.82M	Buy	19,797 +5,759	+41%	+$1.52M	0.06%	61
2018 Q4	$2.67M	Buy	+14,038	New	+$3.42M	0.04%	67

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

C WorldWide Group's TXMD Position: Q2 2022 in Review

C WorldWide Group sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 123,797 shares — an estimated $2.35M sold.

C WorldWide Group first reported a position in TXMD in Q4 2018 and held it in 14 quarters. The position peaked at $11.6M in Q3 2019. 52 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

C WorldWide Group reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
C WorldWide Group sold 123,797 TherapeuticsMD shares in Q2 2022, an estimated $2.35M.
C WorldWide Group first reported a position in TherapeuticsMD in Q4 2018 and held it in 14 quarters.
C WorldWide Group's TherapeuticsMD position peaked at $11.6M in Q3 2019.
52 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on C WorldWide Group's 13F filing for Q2 2022, filed 2 Aug 2022.